| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2021 | CLAREMONT BIOSOLUTIONS LLC | 1182 MONTE VISTA AVE STE 11 | UPLAND | CA | 91786-8205 | SAN BERNARDINO | USA | R44GM131530 | Automated Ultra-Long DNA and RNA Extraction for Long-read Sequencing Applications | 000 | 2 | NIH | 6/17/2025 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $867,721 ) |
| | 2022 | 2022 | CLAREMONT BIOSOLUTIONS LLC | 1182 MONTE VISTA AVE 11 | UPLAND | CA | 91786-8205 | SAN BERNARDINO | USA | R44GM131530 | Automated Ultra-Long DNA and RNA Extraction for Long-read Sequencing Applications | 000 | 3 | NIH | 5/23/2022 | $867,721 |
|
| Issue Date FY: 2021 ( Subtotal = $1,164,571 ) |
| | 2021 | 2021 | CLAREMONT BIOSOLUTIONS LLC | 1182 MONTE VISTA AVE 11 | UPLAND | CA | 91786-8205 | SAN BERNARDINO | USA | R44GM131530 | Automated Ultra-Long DNA and RNA Extraction for Long-read Sequencing Applications | 000 | 2 | NIH | 4/7/2021 | $1,164,571 |
| | 2021 | 2019 | CLAREMONT BIOSOLUTIONS LLC | 1182 MONTE VISTA AVE 11 | UPLAND | CA | 91786-8205 | SAN BERNARDINO | USA | R43CA239967 | Rapid sample preparation method for high molecular weight DNA from tumor tissues suitable for structural variant analysis | 000 | 1 | NIH | 10/13/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $299,988 ) |
| | 2019 | 2019 | CLAREMONT BIOSOLUTIONS LLC | 1182 MONTE VISTA AVE 11 | UPLAND | CA | 91786-8205 | SAN BERNARDINO | USA | R43CA239967 | Rapid sample preparation method for high molecular weight DNA from tumor tissues suitable for structural variant analysis | 000 | 1 | NIH | 4/3/2019 | $299,988 |
| | 2019 | 2018 | CLAREMONT BIOSOLUTIONS LLC | 1182 MONTE VISTA AVE 11 | UPLAND | CA | 91786-8205 | SAN BERNARDINO | USA | R43GM131530 | A novel ultra-long DNA extraction technology for long-read genomic applications | 000 | 1 | NIH | 8/28/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $197,365 ) |
| | 2018 | 2018 | CLAREMONT BIOSOLUTIONS LLC | 1182 MONTE VISTA AVE 11 | UPLAND | CA | 91786-8205 | SAN BERNARDINO | USA | R43GM131530 | A novel ultra-long DNA extraction technology for long-read genomic applications | 000 | 1 | NIH | 9/12/2018 | $197,365 |
|
| Issue Date FY: 2017 ( Subtotal = $0 ) |
| | 2017 | 2015 | CLAREMONT BIOSOLUTIONS LLC | 1182 MONTE VISTA AVE 11 | UPLAND | CA | 91786-8205 | SAN BERNARDINO | USA | R43GM109502 | Automated High-throughput Platform for Tissue Homogenization and RNA Extraction | 000 | 2 | NIH | 1/4/2017 | $0 |
| | 2017 | 2014 | CLAREMONT BIOSOLUTIONS LLC | 1182 MONTE VISTA AVE 11 | UPLAND | CA | 91786-8205 | SAN BERNARDINO | USA | R44AI078619 | A fully integrated assay and platform for detecting Clostridium difficile. | 000 | 5 | NIH | 12/8/2016 | $0 |
|
| Issue Date FY: 2015 ( Subtotal = $342,143 ) |
| | 2015 | 2015 | CLAREMONT BIOSOLUTIONS LLC | 1616 NORTH LAUREL AVENUE | UPLAND | CA | 91784 | SAN BERNARDINO | USA | R43GM109502 | Automated High-throughput Platform for Tissue Homogenization and RNA Extraction | 000 | 2 | NIH | 8/20/2015 | $342,143 |
|
| Issue Date FY: 2014 ( Subtotal = $1,349,366 ) |
| | 2014 | 2014 | CLAREMONT BIOSOLUTIONS LLC | 1616 NORTH LAUREL AVENUE | UPLAND | CA | 91784 | SAN BERNARDINO | USA | R43GM109502 | Automated High-throughput Platform for Tissue Homogenization and RNA Extraction | 000 | 1 | NIH | 8/14/2014 | $349,366 |
| | 2014 | 2014 | CLAREMONT BIOSOLUTIONS LLC | 1616 NORTH LAUREL AVENUE | UPLAND | CA | 91784 | SAN BERNARDINO | USA | R44AI078619 | A fully integrated assay and platform for detecting Clostridium difficile. | 000 | 5 | NIH | 6/27/2014 | $1,000,000 |
|
| Issue Date FY: 2013 ( Subtotal = $1,000,000 ) |
| | 2013 | 2013 | CLAREMONT BIOSOLUTIONS LLC | 1616 NORTH LAUREL AVENUE | UPLAND | CA | 91784 | SAN BERNARDINO | USA | R44AI078619 | A fully integrated assay and platform for detecting Clostridium difficile. | 000 | 4 | NIH | 6/25/2013 | $1,000,000 |
|
| Issue Date FY: 2012 ( Subtotal = $1,000,000 ) |
| | 2012 | 2012 | CLAREMONT BIOSOLUTIONS LLC | 1616 NORTH LAUREL AVENUE | UPLAND | CA | 91784 | SAN BERNARDINO | USA | R44AI078619 | A fully integrated assay and platform for detecting Clostridium difficile. | 000 | 3 | NIH | 6/28/2012 | $1,000,000 |
|
| Issue Date FY: 2010 ( Subtotal = $298,122 ) |
| | 2010 | 2010 | CLAREMONT BIOSOLUTIONS LLC | 1616 NORTH LAUREL AVENUE | UPLAND | CA | 91784 | SAN BERNARDINO | USA | R43AI078619 | A FULLY INTEGRATED ASSAY AND PLATFORM FOR DETECTING CLOSTRIDIUM DIFFICILE | 000 | 2 | NIH | 6/30/2010 | $298,122 |
|
| Issue Date FY: 2009 ( Subtotal = $311,184 ) |
| | 2009 | 2009 | CLAREMONT BIOSOLUTIONS LLC | 1616 NORTH LAUREL AVENUE | UPLAND | CA | 91784 | SAN BERNARDINO | USA | R43AI078619 | A FULLY INTEGRATED ASSAY AND PLATFORM FOR DETECTING CLOSTRIDIUM DIFFICILE | 000 | 1 | NIH | 7/24/2009 | $311,184 |
|
|
